NLS Pharmaceutics Ltd.
NLSP
←Back to Recent Filings
| Filing |
DATE |
FP |
FY |
End Date |
URL |
VIEW |
|
| 6-K |
10/6/2025 |
Q2 |
2025 |
6/30/2025 |
SEC |
view |
|
| 20-F |
5/17/2025 |
Q4 |
2024 |
12/31/2024 |
SEC |
view |
|
| 6-K |
10/18/2024 |
Q2 |
2024 |
6/30/2024 |
SEC |
view |
|
| 20-F |
5/15/2024 |
Q4 |
2023 |
12/31/2023 |
SEC |
view |
|
| 6-K |
12/6/2023 |
Q2 |
2023 |
6/30/2023 |
SEC |
view |
|
| 20-F |
5/5/2023 |
Q4 |
2022 |
12/31/2022 |
SEC |
view |
|
| 6-K |
10/11/2022 |
Q2 |
2022 |
6/30/2022 |
SEC |
view |
|
| 20-F |
3/24/2022 |
Q4 |
2021 |
12/31/2021 |
SEC |
view |
|
| 6-K |
9/28/2021 |
Q2 |
2021 |
6/30/2021 |
SEC |
view |
|
| 20-F |
5/14/2021 |
Q4 |
2020 |
12/31/2020 |
SEC |
view |
|